ES
Enavate Sciences Portfolio holdings
AUM
$177M
This Quarter Return
-27.33%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$133M
AUM Growth
+$133M
(-4.7%)
Cap. Flow
+$34.6M
Cap. Flow
% of AUM
26.07%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
1
Increased
1
Reduced
–
Closed
–
Top Buys
| 1 |
SION
Sionna Therapeutics, Inc. Common Stock
SION
|
$25.9M |
| 2 |
Immunome
IMNM
|
$8.68M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Immunome
IMNM
$820M
| $32.1M | 24.18% |
4,768,583
+1,290,322
| +37% | +$8.68M |
|
|
ZBIO
2
Zenas BioPharma, Inc. Common Stock
ZBIO
$713M
| $29.7M | 22.39% |
3,761,359
| – | – |
|
|
SION
3
Sionna Therapeutics, Inc. Common Stock
SION
$1.11B
| $25.9M | 19.53% |
+2,478,030
| New | +$25.9M |
|
4
CAMP4 Therapeutics Corporation Common Stock
CAMP
$30.4M
| $15.1M | 11.41% |
3,785,802
| – | – |
|
|
UPB
5
Upstream Bio, Inc. Common Stock
UPB
$972M
| $15.1M | 11.34% |
2,459,703
| – | – |
|
6
Compass Therapeutics
CMPX
$476M
| $14.8M | 11.15% |
7,788,150
| – | – |
|